Fiona Brownfoot

2.8k total citations
85 papers, 1.8k citations indexed

About

Fiona Brownfoot is a scholar working on Obstetrics and Gynecology, Pediatrics, Perinatology and Child Health and Immunology. According to data from OpenAlex, Fiona Brownfoot has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Obstetrics and Gynecology, 59 papers in Pediatrics, Perinatology and Child Health and 27 papers in Immunology. Recurrent topics in Fiona Brownfoot's work include Pregnancy and preeclampsia studies (60 papers), Birth, Development, and Health (43 papers) and Reproductive System and Pregnancy (27 papers). Fiona Brownfoot is often cited by papers focused on Pregnancy and preeclampsia studies (60 papers), Birth, Development, and Health (43 papers) and Reproductive System and Pregnancy (27 papers). Fiona Brownfoot collaborates with scholars based in Australia, South Africa and Sweden. Fiona Brownfoot's co-authors include Stephen Tong, Tu’uhevaha J. Kaitu’u‐Lino, Natalie J. Hannan, Roxanne Hastie, Ping Cannon, Sally Beard, Laura Tuohey, Natalie Binder, Kenji Onda and Philippa Middleton and has published in prestigious journals such as PLoS ONE, Scientific Reports and Cochrane Database of Systematic Reviews.

In The Last Decade

Fiona Brownfoot

79 papers receiving 1.8k citations

Peers

Fiona Brownfoot

PPCH

IMMUN

PRM

PHEOH

J. P. Granger United States

R. N. Douglas-Denton Australia

Andromachi Vryonidou Greece

Alev Eroğlu Altınova Türkiye

V. Toescu United Kingdom

Ahmed A. Hasan Germany

Gemma Llauradó Spain

G. B. Melis Italy

V. Kerlan France

Philipp Kalk Germany

J. P. Granger United States

Fiona Brownfoot

387 ×0.3

361 ×0.3

PPCH

199 ×0.4

IMMUN

392 ×1.6

PRM

66 ×0.3

PHEOH

Citations per year, relative to Fiona Brownfoot Fiona Brownfoot (= 1×) peers J. P. Granger

Countries citing papers authored by Fiona Brownfoot

Since Specialization

Citations

This map shows the geographic impact of Fiona Brownfoot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fiona Brownfoot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fiona Brownfoot more than expected).

Fields of papers citing papers by Fiona Brownfoot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fiona Brownfoot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fiona Brownfoot. The network helps show where Fiona Brownfoot may publish in the future.

Co-authorship network of co-authors of Fiona Brownfoot

This figure shows the co-authorship network connecting the top 25 collaborators of Fiona Brownfoot. A scholar is included among the top collaborators of Fiona Brownfoot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fiona Brownfoot. Fiona Brownfoot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cluver, Catherine, Lina Bergman, Henrik Imberg, et al.. (2024). Does metformin prolong pregnancy in preterm pre-eclampsia? A study protocol for a South African, hospital-based double-blind, randomised, placebo-controlled trial. BMJ Open. 14(6). e082880–e082880. 3 indexed citations

Baird, L G, Ping Cannon, Fiona Brownfoot, et al.. (2023). Paternal Expressed Gene 10 (PEG10) is decreased in early-onset preeclampsia. Reproductive Biology and Endocrinology. 21(1). 65–65. 4 indexed citations

Binder, Natalie, et al.. (2023). Sulfasalazine for the treatment of preeclampsia in a nitric oxide synthase antagonist mouse model. Placenta. 132. 20–26. 5 indexed citations

Palaniswami, Marimuthu, et al.. (2023). The Effect of Fetal Heart Rate Segment Selection on Deep Learning Models for Fetal Compromise Detection. PubMed. 2023. 1–4. 1 indexed citations

Brownfoot, Fiona, et al.. (2023). An LC-MS/MS method for the simultaneous quantitation of sulfasalazine and sulfapyridine in human placenta. Journal of Pharmaceutical and Biomedical Analysis. 235. 115633–115633. 3 indexed citations

Binder, Natalie, Sally Beard, Natasha Pritchard, et al.. (2022). Actions of Esomeprazole on the Maternal Vasculature in Lean and Obese Pregnant Mice with Impaired Nitric Oxide Synthesis: A Model of Preeclampsia. International Journal of Molecular Sciences. 23(15). 8185–8185. 3 indexed citations

Lindquist, Anthea, et al.. (2022). Time to resolution of tubal ectopic pregnancy following methotrexate treatment: A retrospective cohort study. PLoS ONE. 17(5). e0268741–e0268741. 6 indexed citations

Binder, Natalie, Sally Beard, James Cuffe, et al.. (2022). The L-NAME mouse model of preeclampsia and impact to long-term maternal cardiovascular health. Life Science Alliance. 5(12). e202201517–e202201517. 28 indexed citations

Hannan, Natalie J., et al.. (2022). Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro. PLoS ONE. 17(11). e0271560–e0271560. 8 indexed citations

10.

Cluver, Catherine, Richard Hiscock, Eric Decloedt, et al.. (2021). Use of metformin to prolong gestation in preterm pre-eclampsia: randomised, double blind, placebo controlled trial. BMJ. 374. n2103–n2103. 66 indexed citations

11.

Keenan, Emerson, et al.. (2020). Entropy Profiling for Detection of Fetal Arrhythmias in Short Length Fetal Heart Rate Recordings. PubMed. 2020. 621–624. 5 indexed citations

12.

Binder, Natalie, Fiona Brownfoot, Sally Beard, et al.. (2020). Esomeprazole and sulfasalazine in combination additively reduce sFlt-1 secretion and diminish endothelial dysfunction: potential for a combination treatment for preeclampsia. Pregnancy Hypertension. 22. 86–92. 13 indexed citations

13.

Brownfoot, Fiona, Natalie J. Hannan, Susan Walker, et al.. (2019). A Systematic Review of Proton Pump Inhibitors for the Prevention and Treatment of Preeclampsia and Gestational Hypertension. Open Journal of Obstetrics and Gynecology. 9(1). 21–28. 1 indexed citations

14.

Cluver, Catherine, Susan Walker, Ben W. Mol, et al.. (2019). A double blind, randomised, placebo-controlled trial to evaluate the efficacy of metformin to treat preterm pre-eclampsia (PI2 Trial): study protocol. BMJ Open. 9(4). e025809–e025809. 37 indexed citations

15.

Hastie, Roxanne, Fiona Brownfoot, Ping Cannon, et al.. (2019). Sulfasalazine decreases soluble fms-like tyrosine kinase-1 secretion potentially via inhibition of upstream placental epidermal growth factor receptor signalling. Placenta. 87. 53–57. 11 indexed citations

16.

Hastie, Roxanne, Louie Ye, Natalie J. Hannan, et al.. (2018). Disulfiram inhibits placental soluble FMS-like tyrosine kinase-1 and soluble endoglin secretion independent of the proteasome. Pregnancy Hypertension. 14. 125–130. 2 indexed citations

17.

Ye, Louie, Fiona Brownfoot, Natalie J. Hannan, et al.. (2016). Steroid sulfatase is increased in the placentas and whole blood of women with early-onset preeclampsia. Placenta. 48. 72–79. 8 indexed citations

18.

Kaitu’u‐Lino, Tu’uhevaha J., Roxanne Hastie, Natalie J. Hannan, et al.. (2016). Loss of Akt increases soluble endoglin release from endothelial cells but not placenta. Pregnancy Hypertension. 6(2). 95–102. 9 indexed citations

19.

Hastie, Roxanne, Stephen Tong, Natalie J. Hannan, et al.. (2016). Epidermal Growth Factor Rescues Endothelial Dysfunction in Primary Human Tissues In Vitro. Reproductive Sciences. 24(9). 1245–1252. 13 indexed citations

20.

Brownfoot, Fiona, Natalie J. Hannan, Kenji Onda, Stephen Tong, & Tu’uhevaha J. Kaitu’u‐Lino. (2014). Soluble endoglin production is upregulated by oxysterols but not quenched by pravastatin in primary placental and endothelial cells. Placenta. 35(9). 724–731. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact